发明名称 COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ERLOTINIB, AND METHODS OF USE
摘要 The invention provides A combination of, a) a compound of Formula (I) or a pharmaceutically acceptable salt thereof; and b) erlotinib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.
申请公布号 SG194052(A1) 申请公布日期 2013.11.29
申请号 SG20130073788 申请日期 2012.03.30
申请人 GENENTECH, INC. 发明人 NANNINI, MICHELLE;SAMPATH, DEEPAK
分类号 主分类号
代理机构 代理人
主权项
地址